These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment. Studenberg SD; Brouwer KL J Pharmacol Exp Ther; 1992 Jun; 261(3):1022-7. PubMed ID: 1602370 [TBL] [Abstract][Full Text] [Related]
4. Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1. Zamek-Gliszczynski MJ; Hoffmaster KA; Tian X; Zhao R; Polli JW; Humphreys JE; Webster LO; Bridges AS; Kalvass JC; Brouwer KL Drug Metab Dispos; 2005 Aug; 33(8):1158-65. PubMed ID: 15860656 [TBL] [Abstract][Full Text] [Related]
5. Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions. Patel NJ; Zamek-Gliszczynski MJ; Zhang P; Han YH; Jansen PL; Meier PJ; Stieger B; Brouwer KL Mol Pharmacol; 2003 Jul; 64(1):154-9. PubMed ID: 12815171 [TBL] [Abstract][Full Text] [Related]
6. Effect of phenobarbital and p-hydroxyphenobarbital glucuronide on acetaminophen metabolites in isolated rat hepatocytes: use of a kinetic model to examine the rates of formation and egress. Studenberg SD; Brouwer KL J Pharmacokinet Biopharm; 1993 Apr; 21(2):175-94. PubMed ID: 8229679 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of 5 (and 6)-carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liver. Zamek-Gliszczynski MJ; Xiong H; Patel NJ; Turncliff RZ; Pollack GM; Brouwer KL J Pharmacol Exp Ther; 2003 Feb; 304(2):801-9. PubMed ID: 12538836 [TBL] [Abstract][Full Text] [Related]
8. Acute phenobarbital administration alters the disposition of acetaminophen metabolites in the rat. Brouwer KL Drug Metab Dispos; 1993; 21(6):1129-33. PubMed ID: 7905395 [TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2. Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906 [TBL] [Abstract][Full Text] [Related]
10. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier. Brouwer KL; Jones JA J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593 [TBL] [Abstract][Full Text] [Related]
11. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver. Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505 [TBL] [Abstract][Full Text] [Related]
12. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Slitt AL; Cherrington NJ; Maher JM; Klaassen CD Drug Metab Dispos; 2003 Sep; 31(9):1176-86. PubMed ID: 12920174 [TBL] [Abstract][Full Text] [Related]
13. Ethynylestradiol increases expression and activity of rat liver MRP3. Ruiz ML; Villanueva SS; Luquita MG; Vore M; Mottino AD; Catania VA Drug Metab Dispos; 2006 Jun; 34(6):1030-4. PubMed ID: 16554369 [TBL] [Abstract][Full Text] [Related]
14. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats. Chen C; Hennig GE; Manautou JE Drug Metab Dispos; 2003 Jun; 31(6):798-804. PubMed ID: 12756215 [TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance-associated protein 2 is primarily responsible for the biliary excretion of fexofenadine in mice. Tian X; Zamek-Gliszczynski MJ; Li J; Bridges AS; Nezasa K; Patel NJ; Raub TJ; Brouwer KL Drug Metab Dispos; 2008 Jan; 36(1):61-4. PubMed ID: 17913796 [TBL] [Abstract][Full Text] [Related]
16. Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney. Li CY; Basit A; Gupta A; Gáborik Z; Kis E; Prasad B J Steroid Biochem Mol Biol; 2019 Jul; 191():105350. PubMed ID: 30959153 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- mice. Zamek-Gliszczynski MJ; Nezasa K; Tian X; Bridges AS; Lee K; Belinsky MG; Kruh GD; Brouwer KL J Pharmacol Exp Ther; 2006 Dec; 319(3):1485-91. PubMed ID: 16988054 [TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism. Lecureux L; Dieter MZ; Nelson DM; Watson L; Wong H; Gemzik B; Klaassen CD; Lehman-McKeeman LD Toxicol Sci; 2009 Apr; 108(2):482-91. PubMed ID: 19211616 [TBL] [Abstract][Full Text] [Related]
19. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3. Chu XY; Huskey SE; Braun MP; Sarkadi B; Evans DC; Evers R J Pharmacol Exp Ther; 2004 Apr; 309(1):156-64. PubMed ID: 14722317 [TBL] [Abstract][Full Text] [Related]
20. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice. Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]